Immunogenicity and Protective Effect of Live Cold-Adapted Vaccines against Influenza B after Intranasal Immunization of Mice
https://doi.org/10.31631/2073-3046-2015-14-4-80-85
Abstract
Live attenuated («att») vaccines based on cold-adapted («ca») strains are a promising approach of influenza prophylaxis enhancement, however, effectiveness evaluation as well as interrelation with immunogenicity should be elucidated, especially for vaccines against type B influenza.
Sterile, pure and concentrated viruses were prepared using a parent wild-type influenza type B and a live «ca» strain derived from the wild-type strain, and their biological activity and phenotype were fully characterized. Mice intranasally immunized twice with the live «ca» vaccines developed sterile immunity (wild-type virus was not isolated in chicken embryos (below limit of detection) from lungs of immunized and subsequently infected mice), however, sera antibodies in hemagglutination inhibition test (HAI) were also not detected (below limit of detection).
Live «ca» vaccines against influenza type B viruses are effective, however, protection from infection was not determined by HAI antibodies. Further studies using various methods of immunogenicity evaluation and characterization of mechanisms of protection for influenza vaccines, first of all «att», are needed.
About the Authors
O. S. Kashirina
Federal State Budgetary Institution «I.I. Mechnikov’s Research institute for vaccines and sera»
Russian Federation
Russian Federation
Y. M. Vasiliev
Federal State Budgetary Institution «I.I. Mechnikov’s Research institute for vaccines and sera»
Russian Federation
Russian Federation
References
1. WHO. Vaccines against influenza WHO position paper. November 2012. WER. 2012; 47: 461 – 476.
2. WHO. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. WER. 2015; 12: 109 – 120.
3. Vasiliev Y.M. Directions of influenza vaccine enhancement. Physician. 2014; 8: 12-14 (in Russian).
4. Vasiliev Y.M. Neuraminidase inhibitors for specific prophylaxis and therapy of influenza. Physician. 2014; 2: 17 – 19 (in Russian).
5. Kashirina O.S., Vasiliev Y.M. Live attenuated and inactivated influenza vaccines: data from direct comparative studies. Journal of Microbiology. 2014; 1: 103 – 119 (in Russian).
6. Treanor J., Kotloff K., Betts R., Belshe R., Newman F., Iacuzio D. et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine. 1999; 18: 899 – 906.
7. Ghendon Y.Z. , Markushin S.G., Akopova I.I., Tsfasman T.M., Koptiaeva I.B. A cold-adapted strain of influenza virus B-B/Victoria/2/63/87 as a strain-donor of attenuation for production of cold-adapted reassortant strains for a live influenza vaccine. Patent RU, N 2 529 772; 2013 (in Russian).
8. Ghendon Y.Z., Markushin S.G., Tsfasman T.M., Akopova I.I., Akhmatova N.K., Koptiaeva I.B. New cold-adapted donor strains of attenuation for live influenza vaccines. Problems of Virology. 2013; 1: 11 – 17 (in Russian).
9. WHO manual on animal influenza diagnosis and surveillance. 2002. 10. MD 3.3.2.175803. Methods of determination of parameters of quality of immunobiological preparations for prophylaxis and diagnostics of influenza. 2003 (in Russian).
10. SR 1.3.2322-08. Safety of working with microorganisms of III-IV group of pathogenicity (danger) and causative agents of parasitic diseases. 2008 (in Russian).
Review
For citations:
Kashirina O.S., Vasiliev Y.M. Immunogenicity and Protective Effect of Live Cold-Adapted Vaccines against Influenza B after Intranasal Immunization of Mice. Epidemiology and Vaccinal Prevention. 2015;14(4):80-85. (In Russ.) https://doi.org/10.31631/2073-3046-2015-14-4-80-85
Views:
772
Email this article 